...
首页> 外文期刊>Molecular pain >Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure
【24h】

Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure

机译:持续暴露于阿片类药物后,脊髓基因表达的表观遗传调控有助于增加术后疼痛和镇痛耐受性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Opioids have become the mainstay for treatment of moderate to severe pain and are commonly used to treat surgical pain. While opioid administration has been shown to cause opioid-induced hyperalgesia and tolerance, interactions between opioid administration and surgery with respect to these problematic adaptations have scarcely been addressed. Accumulating evidence suggests opioids and nociceptive signaling may converge on epigenetic mechanisms in spinal cord to enhance or prolong neuroplastic changes. Epigenetic regulation of Bdnf (brain-derived neurotrophic factor) and Pdyn (prodynorphin) genes may be involved. Four days of ascending doses of morphine treatment caused opioid-induced hyperalgesia and reduced opioid analgesic efficacy in mice. Both opioid-induced hyperalgesia and the reduced opioid analgesic efficacy were enhanced in mice that received hindpaw incisions. The expression of Bdnf and Pdyn (qPCR) was increased after morphine treatment and incision. Chromatin immunoprecipitation assays demonstrated that the Pdyn and Bdnf promoters were more strongly associated with acetylated H3K9 after morphine plus incision than in the morphine or incision alone groups. Selective tropomyosin-related kinase B (ANA-12) and κ-opioid receptor (nor-binaltorphimine) antagonists were administered intrathecally, both reduced hyperalgesia one or three days after surgery. Administration of ANA-12 or nor-binaltorphimine attenuated the decreased morphine analgesic efficacy on day 1, but only nor-binaltorphimine was effective on day 3 after incision in opioid-exposed group. Coadministration of histone acetyltransferase inhibitor anacardic acid daily with morphine blocked the development of opioid-induced hyperalgesia and attenuated incision-enhanced hyperalgesia in morphine-treated mice. Anacardic acid had similar effects on analgesic tolerance, showing the involvement of histone acetylation in the interactions detected. Spinal epigenetic changes involving Bdnf and Pdyn may contribute to the enhanced postoperative nociceptive sensitization and analgesic tolerance observed after continuous opioid exposure. Treatments blocking the epigenetically mediated up-regulation of these genes or administration of TrkB or κ-opioid receptor antagonists may improve the clinical utility of opioids, particularly after surgery.
机译:阿片类药物已成为治疗中度至重度疼痛的主要药物,通常用于治疗手术疼痛。尽管已证明阿片类药物的给药会引起阿片类药物引起的痛觉过敏和耐受性,但针对这些有问题的适应性问题,阿片类药物的给药与手术之间的相互作用尚未得到解决。越来越多的证据表明,阿片类药物和伤害性信号可能会聚集在脊髓的表观遗传机制上,以增强或延长神经增生性改变。可能涉及Bdnf(脑源性神经营养因子)和Pdyn(强啡肽)基因的表观遗传调控。持续四天的吗啡治疗剂量会导致阿片类药物引起的痛觉过敏,并降低阿片类药物的镇痛效果。阿片类药物引起的痛觉过敏和阿片类药物的镇痛效果均在接受后足切口的小鼠中得到增强。吗啡处理和切开后,Bdnf和Pdyn(qPCR)的表达增加。染色质免疫沉淀分析表明,与吗啡或单独切口组相比,吗啡加切口后Pdyn和Bdnf启动子与乙酰化H3K9的关联更紧密。鞘内注射选择性原肌球蛋白相关激酶B(ANA-12)和κ阿片受体(nor-binaltorphimine)拮抗剂,均在术后1或3天减轻痛觉过敏。在暴露于阿片类药物的组中,ANA-12或去甲甲萘酚碱的给药在第1天减弱了吗啡止痛效果,但仅去甲乙甲酚碱在切开后的第3天有效。每天将组蛋白乙酰基转移酶抑制剂漆树酸与吗啡并用会阻断阿片类药物诱导的小鼠中阿片类药物引起的痛觉过敏和切口增强的痛觉过敏。熊果酸对镇痛耐受性具有相似的作用,表明组蛋白乙酰化参与了所检测的相互作用。持续暴露于阿片类药物后,涉及Bdnf和Pdyn的脊髓表观遗传变化可能有助于增强术后伤害性敏化和止痛耐受性。阻止这些基因的表观遗传学介导的上调治疗或施用TrkB或κ阿片受体拮抗剂可以改善阿片的临床效用,尤其是在手术后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号